Biogen Stock Popped: Here's What Happened In Its Alzheimer's UpdateInvestors Business Daily • 12/05/19
Biogen Inc. (BIIB) Management Presents at Evercore ISI 2nd Annual HealthCONx Conference (Transcript)Seeking Alpha • 12/04/19
Biogen Announces Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)GlobeNewsWire • 12/03/19
Biogen's stock could fall 10% on new Alzheimer's drug data this week, top analyst saysCNBC • 12/02/19
Biogen's Alzheimer's Drug 'Falls Far Short Of Compelling Argument For Approval,' Baird Says In DowngradeBenzinga • 12/02/19
Biogen Stock Is Facing A Crucial Test — Here's What You Need To KnowInvestors Business Daily • 12/02/19
Biogen Presents Data Demonstrating Improved Gastrointestinal Tolerability With VUMERITY™ (diroximel fumarate) Compared to TECFIDERA® (dimethyl fumarate)GlobeNewsWire • 11/22/19
Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study for an Inherited Retinal DisorderGlobeNewsWire • 11/21/19